Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.02 M USD
1.61 M USD
117.80 M
About FILAMENT HEALTH CORP.
Sector
CEO
Benjamin Lightburn
Headquarters
Burnaby
Website
Founded
2020
FIGI
BBG012DBRYR2
Filament Health Corp. is a clinical-stage natural psychedelic drug development company, which engages in the discovery and development of natural psychedelic pharmaceuticals. It focuses on the discovery, development, and delivery of natural psychedelic medicines for clinical development. The company was founded by Benjamin Lightburn and Tom Kineshanko on June 8, 2020 and is headquartered in Burnaby, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FLHLF is 0.0334 USD — it has increased by 18.00% in the past 24 hours. Watch Filament Health Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Filament Health Corp. stocks are traded under the ticker FLHLF.
FLHLF stock has risen by 19.88% compared to the previous week, the month change is a 4.56% rise, over the last year Filament Health Corp. has showed a −73.49% decrease.
FLHLF reached its all-time high on Nov 22, 2021 with the price of 0.3680 USD, and its all-time low was 0.0066 USD and was reached on Jan 3, 2023. View more price dynamics on FLHLF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Filament Health Corp. financials in yearly and quarterly reports right on TradingView.
Filament Health Corp. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
FLHLF net income for the last quarter is −721.62 K USD, while the quarter before that showed −753.81 K USD of net income which accounts for 4.27% change. Track more Filament Health Corp. financial stats to get the full picture.
No, FLHLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has 13.00 employees. See our rating of the largest employees — is Filament Health Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Filament Health Corp. EBITDA is −2.57 M USD, and current EBITDA margin is −221.07%. See more stats in Filament Health Corp. financial statements.
Like other stocks, FLHLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Filament Health Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Filament Health Corp. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Filament Health Corp. stock shows the sell signal. See more of Filament Health Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.